MARKET

CMPS

CMPS

Compass Pathways Plc
NASDAQ
13.14
-0.40
-2.95%
Opening 14:01 08/10 EDT
OPEN
13.60
PREV CLOSE
13.54
HIGH
13.62
LOW
13.07
VOLUME
1.12M
TURNOVER
--
52 WEEK HIGH
15.40
52 WEEK LOW
3.970
MARKET CAP
1.82B
P/E (TTM)
-3.7841
1D
5D
1M
3M
1Y
5Y
1D
COMPASS Pathways (CMPS) Gets a Buy from Evercore ISI
TipRanks · 5h ago
Weekly Report: what happened at CMPS last week (0803-0807)?
Weekly Report · 9h ago
COMPASS Pathways (CMPS) Joins VA PIVOT Trial, Is The Stock Still Cheap?
Simply Wall St · 1d ago
Analysts’ Top Healthcare Picks: COMPASS Pathways (CMPS), Trulieve Cannabis (TRLV)
TipRanks · 2d ago
COMPASS Pathways (CMPS) Stock Looks Stretched Following Its 214% One Year Run
Simply Wall St · 3d ago
Unusually active option classes on open August 7th
TipRanks · 3d ago
Compass Pathways Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 3d ago
Compass Pathways Price Target Cut to $65.00/Share From $70.00 by HC Wainwright & Co.
Dow Jones · 3d ago
More
About CMPS
Compass Pathways plc is a United Kingdom-based biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The Company is engaged in treating mental health conditions focused on rapid and durable responses through the development of its investigational COMP360 psilocybin treatment. COMP360 is its psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. The Company’s initial focus is on treatment-resistant depression (TRD), comprising patients who are inadequately served by the current treatment paradigm. It commenced its Phase III program evaluating its COMP360 psilocybin treatment in TRD. In addition, the Company has ongoing Phase II trials in PTSD and anorexia nervosa. It also provides support to research institutions conducting investigator-initiated studies with COMP360 psilocybin in areas of serious unmet need.

Webull offers Compass Pathways PLC (ADR) stock information, including NASDAQ: CMPS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CMPS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CMPS stock methods without spending real money on the virtual paper trading platform.